Molecular Partners AG Files 2024 Annual Report
Ticker: MOLN · Form: 20-F · Filed: Mar 6, 2025 · CIK: 1745114
Sentiment: neutral
Topics: annual-report, financials, biotech
TL;DR
Molecular Partners AG dropped its 2024 20-F. Check financials for 2021-2024.
AI Summary
Molecular Partners AG filed its 20-F for the fiscal year ending December 31, 2024. The filing provides a comprehensive overview of the company's financial position and business operations. Key financial data from previous years, including 2021, 2022, and 2023, are also included for comparative analysis.
Why It Matters
This filing provides investors with crucial financial and operational details for Molecular Partners AG, enabling informed investment decisions. It outlines the company's performance and financial health over the past fiscal year.
Risk Assessment
Risk Level: medium — As a 20-F filing, it primarily contains historical financial data and disclosures, with the inherent risks associated with the biotechnology sector not explicitly detailed in this summary.
Key Numbers
- 2024 — Fiscal Year End (Primary reporting period for the 20-F)
- 2023 — Previous Fiscal Year End (For comparative financial analysis)
- 2022 — Previous Fiscal Year End (For comparative financial analysis)
- 2021 — Previous Fiscal Year End (For comparative financial analysis)
Key Players & Entities
- Molecular Partners AG (company) — Filer of the 20-F report
- 2024-12-31 (date) — Fiscal year end date
- 2021-12-31 (date) — Comparative fiscal year end date
- 2022-12-31 (date) — Comparative fiscal year end date
- 2023-12-31 (date) — Comparative fiscal year end date
FAQ
What is the primary purpose of this 20-F filing?
The 20-F filing for Molecular Partners AG serves as its annual report, providing comprehensive financial information and business disclosures for the fiscal year ending December 31, 2024.
What fiscal years are covered by the financial data in this filing?
The filing covers the fiscal year ending December 31, 2024, and includes comparative data for the fiscal years ending December 31, 2021, 2022, and 2023.
What is the company's Standard Industrial Classification (SIC) code?
Molecular Partners AG's SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Where is Molecular Partners AG headquartered?
Molecular Partners AG is headquartered at Wagistrasse 14, Zurich-Schlieren, V8, 8952.
What stock exchange is mentioned in relation to the company's American Depository Shares?
The filing mentions 'moln:AmericanDepositorySharesTheNasdaqStockMarketLLCMember', indicating a relationship with The Nasdaq Stock Market LLC.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 6, 2025 regarding MOLECULAR PARTNERS AG (MOLN).